Avidity Biosciences vs Caris Life Sciences
Avidity Biosciences vs Caris Life Sciences, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Caris Life Sciences on 59/100.
Where each one leads
Avidity Biosciences
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 53/100
- agent readiness: 47/100 against 37/100
- domain rating: 63/100 against 46/100
- headcount: 1,659 against 445
- funding raised: $700M against $495M
- LinkedIn following: 77,698 against 37,705
At a glance
| Measure | Avidity Biosciences | Caris Life Sciences |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | 2008 |
| Headquarters | San Diego, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Caris Life Sciences |
|---|---|---|
| Employees | 445 | 1,659 |
| Total funding | $495M | $700M |
| Latest round | IPO | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | 37,705 | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 59/100 |
| Traction | 60/100 | 60/100 |
| Search visibility | 22/100 | 22/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Caris Life Sciences |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Avidity Biosciences vs Caris Life Sciences: common questions
Which is better, Avidity Biosciences or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 53/100), agent readiness (47/100 against 37/100), domain rating (63/100 against 46/100), headcount (1,659 against 445), funding raised ($700M against $495M), LinkedIn following (77,698 against 37,705).
Read the full Avidity Biosciences review and pricing or the Caris Life Sciences review and pricing. You can also browse other Avidity Biosciences alternatives we track.